RPI Researchers Aim to Manufacture mRNA More Affordably
Rensselaer Polytechnic Institute (RPI)Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology. The team’s work will focus on improving mRNA manufacturing. Synthetizing mRNA vaccines involves a series of complex chemical reactions.